$BKLLF / $CODE These new drug delivery systems could potentially provide an innovation for those long-term patients suffering from malaria, lupus and rheumatoid arthritis who have depended on HCQ for decades and have had to accept the side effects related to oral tablet delivery.
While there has been widespread publicity concerning HCQ as a treatment for Covid-19, there has been no recognized drug trial results to date.
https://www.finanznachrichten.de/nachrichten-...ts-200.htm
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!